Kalvista Pharmaceuticals Inc (NASDAQ: KALV) — Healthcare · Share Price, Chart & Market Data
About: KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kallikrein for the treatment of acute attacks of hereditary angioedema (HAE). The company is also developing is developing an orally disintegrating tablet formulation; KONFIDENT-KID for pediatric use with HAE; KONFIDENT; and KONFIDENT-S to evaluate sebetralstat and ODT formulation in adolescent and adult patients. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $19.56 (-6.23%)
KALVKalvista Pharmaceuticals Inc
Loading watchlist status…
Trade KALV now
Kalvista Pharmaceuticals Inc share price
KALV price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
17 Apr, 6:18 am GMT+0
KALV price performance
0.877%
5D
16.29%
1M
26.52%
YTD
66.539%
1Y
KALV price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
17 Apr, 6:18 am GMT+0
KALV details
KALV Market Signals